General Gynecology Breast Health

Gonadotropin level abnormalities in women with cyclic mastalgia

Ecochard R, Marret H, Rabilloud M, Boehringer H, Mathieu C, Guerin JF

Published January 2001 European journal of obstetrics, gynecology, and reproductive biology
DOI 10.1016/s0301-2115(00)00322-5 PMID 11134832

Abstract

Objectives

Women with cyclic mastalgia seem to be at risk of fibrocystic breast disease and/or breast cancer. We studied the relationships between mastalgia and hormone levels throughout the menstrual cycle.

Study Design

Ostensibly healthy women were monitored during a sum of 326 cycles. A case-control study compared personal and hormonal variables of 30 women experiencing cyclic mastalgia with those of 77 women without this symptom.

Results

Except sleeping times, no significant differences were found in personal variables. Cyclic mastalgia and symptoms of fluid retention were slightly associated. Menses and the luteal phase were significantly longer in cases than in controls. Gonadotropin but not ovarian hormone levels were also significantly higher in cases throughout the cycle.

Conclusion

Cyclic mastalgia is less related to symptoms of fluid retention or to ovarian hormone levels than to regularly high gonadotropin levels, specific inhibitors might thus be used to alleviate the symptom.

Topics

By this author

Related research

General Gynecology › Breast Health › Benign Breast Conditions · Diagnostics › Hormone Testing › Serum Panels
René Ecochard, Henri Marret, Muriel Rabilloud, Hans Boehringer, Claudine Mathieu, Jean-François Guerin
R Ecochard, H Marret, M Rabilloud, H Boehringer, C Mathieu, J Guerin
PMID 11134832 11134832 DOI 10.1016/s0301-2115(00)00322-5 10.1016/s0301-2115(00)00322-5 Ecochard et al. 2001, Ecochard 2001